President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the ...

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...

But it’s unclear if the evidence provided to support continued use of fluoridated supplements will matter. The FDA said in ...

Columbia University agreed Wednesday to pay more than $220 million in a deal with the Trump administration to restore federal ...

Nutrition education in medical schools can be a chance to emphasize the importance of talking about food without judgment.

States are unlikely to fully neutralize the Medicaid cuts — but they have tools to scuttle the Trump administration's efforts ...

Some genetically targeted therapies are classified in the IRA as small-molecule drugs, limiting the incentive for biotech ...

UnitedHealth Group on Thursday confirmed the Department of Justice has launched both criminal and civil investigations into ...

To suggest Sarepta Therapeutics may not survive its gene therapy crisis is a sobering claim to make, STAT's Adam Feuerstein ...

Cognitive behavioral therapy is known to be beneficial for people with chronic pain, but accessing that care can be difficult ...